Position in BBNX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,925,793
+$935,779 QoQ
Shares Held
122,897
+24.4% QoQ
Ownership
0.273%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 133 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $5,923,174,094 across 79 Medical Devices names. BBNX ranks #45 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
14,084,483 | $1,274,082,319 | |
| 2 | MDT |
Medtronic plc
|
14,694,253 | $1,149,531,398 | |
| 3 | SYK |
Stryker Corp
|
3,548,516 | $1,117,214,769 | |
| 4 | ABT |
Abbott Laboratories
|
9,991,899 | $906,664,905 | |
| 5 | BSX |
Boston Scientific Corp
|
7,943,553 | $339,030,832 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,639,900 | $168,979,991 | |
| 7 | DXCM |
Dexcom Inc
|
2,309,648 | $155,554,782 | |
| 8 | STE |
STERIS plc
|
503,402 | $106,001,351 |
All Filings in BBNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,925,793 | 122,897 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $990,014 | 98,804 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,040,386 | 99,783 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,790,642 | 90,118 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $398,258 | 27,353 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $315,705 | 25,793 | Shares | Defined | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||